Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use Between 2013 and 2017
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0877
Full Text
Open PDFAbstract
Available in full text
Date
October 31, 2018
Authors
Publisher
American Association for Cancer Research (AACR)